Clinical trial CL1-95012-001
A first in human Phase 1/2 open-label, multicenter, dose escalation and expansion study of PRS-344/S095012 in patients with solid tumors
| Organ | Multiple |
|---|---|
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Servier |
| EudraCT Identifier | 2019-003456-36 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05159388 |
| Last update |